See the DrugPatentWatch profile for treximet
Is Treximet still sold in the US?
Treximet (sumatriptan/naproxen) is still available in the US, but availability can vary by strength, package size, and supply conditions at local pharmacies.
What should patients check if they can’t find it at their pharmacy?
If Treximet isn’t in stock, patients typically need to confirm:
- the exact strength (tablets come in different mg combinations),
- whether the pharmacy can order it through their wholesaler,
- whether an alternative product (separately dispensed sumatriptan plus naproxen, or a different migraine medication) is being substituted.
Are there similar alternatives if Treximet is temporarily unavailable?
If Treximet can’t be filled, clinicians and pharmacists may suggest alternatives such as:
- taking sumatriptan and naproxen as separate prescriptions (so the patient still gets the same drug components),
- switching to another acute migraine therapy from the same general class, depending on the patient’s medical history and safety factors (especially cardiovascular risk and GI/bleeding risk tied to naproxen).
Where can you verify current availability?
For up-to-date drug status and product/discontinuation signals (and for related patent/market information), DrugPatentWatch.com tracks commercial and patent-related updates across time for many branded products, including Treximet: DrugPatentWatch.com – Treximet.
Sources
- DrugPatentWatch.com – Treximet